Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 2.3
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries chemicals, vaccines, biologics, and drug substances at room temperature. The company was founded in 2017 and is headquartered in Lund, Sweden.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E. Editor's note: P/CR is Price to Core Revenue (
Data is available to registered users only
Buy
Sell